secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001636422-21-000075
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q3 revenue beats guidance, adjusted EBITDA loss improves 10%
----------------------------------------------------------------------------

- Total revenue $61.7 million (+31% YoY); technology revenue $38.3 million (+37%) and professional services $23.5 million (+22%).
- GAAP net loss $40 million (vs $27.3 million loss in Q3 2020); operating loss $42.2 million (vs $23.5 million).
- Adjusted EBITDA loss $(5.8) million improved 10% from $(6.4) million loss in prior-year quarter.
- Adjusted technology gross margin 70% (up from 68%); total adjusted gross margin flat at 51%.
- CEO Dan Burton noted strong Q3 performance, exceeding mid-point of guidance for both revenue and adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642221000075/0001636422-21-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642221000075/hcat-20211109.htm
  HTML page:      https://secwatch.observer/filing/0001636422-21-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer